Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

University of Pennsylvania, UPMC Hillman Cancer Center, University of Chicago, University of Melbourne, St Vincent's Hospital, Peter MacCallum Cancer Centre, St. Vincent's Hospital, Emory University, University Hospital Cologne, The University of Kansas Cancer Center, Medical University of Vienna, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, The University of Texas MD Anderson Cancer Center, Hôpital Maisonneuve-Rosemont, Université de Montréal, University of Minnesota, Juravinski Hospital, McMaster University, Royal Prince Alfred Hospital, University of Sydney, University Medical Center, Karolinska Institutet, University of Michigan–Ann Arbor, Michigan Center for Translational Pathology, Oslo University Hospital, Novartis (Switzerland), Novartis (France), Novartis Institutes for BioMedical Research, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Oregon Health & Science University